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Abigail Silvers and Colleen Scarpato: Main Line Health Community Clinical Oncology Program

Main Line Health Community Clinical
Oncology Program
The National Cancer Institute (NCI), recognizing that more than 80% of cancers in
this country are diagnosed and treated in local communities, established the
Community Clinical Oncology program (CCOP) in 1983. The aim of the project was to
provide cancer patients with access to NCI-sponsored cancer treatment trials and upto-date cancer management in patients' own communities. Three years later, the
NCI expanded the CCOP focus to include cancer prevention and control research.
In 1994, the cancer programs of the three acute care hospitals of Main Line Health
(Bryn Mawr, Lankenau and Paoli Memorial) were awarded a CCOP designation by the
NCI. The Main Line Health CCOP has access to cancer prevention and treatment
protocols from four research bases: M.D. Anderson Cancer Center, the Eastern
Cooperative Oncology Group, the Radiation Therapy Oncology Group and the
National Surgical Adjuvant Breast and Bowel Project. Through the dedication and
efforts of our medical, radiation and surgical oncologists, as well as our data
managers, Main Line Health successfully met all of its CCOP goals. On recent
resubmission, we were awarded a five-year extension of our NCI grant.
Through the CCOP, Main Line Health is able to offer innovative cancer treatment and
new approaches to cancer prevention and control to area physicians and their
patients. Primary health care providers and specialists are increasingly involved with
our CCOP investigators in the conduct of clinical research trials. This ongoing
collaboration facilitates education about new strategies in cancer care and prevention
as well as how these advancements may impact on community medical practices.
Our CCOP is involved with a variety of community activities of the Main Line Health
Community Services, including cancer screenings, educational programs, and health
fairs, which increases our access to women's groups, minorities and the underserved
population. Continued interaction with community leaders provides the CCOP with an
opportunity to address their concerns about research protocols as well as to
determine appropriate responses to their needs.
By increasing community awareness and fostering participation in clinical research
protocols, the individual and societal impact of cancer can be addressed. Prevention
and early detection strategies, state-of-the-art treatment technologies, and novel
approaches to patient management and rehabilitation are all areas of cancer care
that are now available at the community level through the CCOP.
Anyone wishing additional information about the Main Line Health Community Clinical
Oncology Program and its cancer research studies may contact the Program
Administrative Director, Colleen Scarpato, BSN at (610) 645-2680 or the Principal
Investigator, Abigail Silvers, MD at (610) 649-5080.
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